Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
99.74
-2.38 (-2.33%)
At close: Sep 8, 2025, 4:00 PM
99.77
+0.03 (0.03%)
After-hours: Sep 8, 2025, 4:00 PM EDT
Rhythm Pharmaceuticals Stock Forecast
Stock Price Forecast
The 13 analysts that cover Rhythm Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $101.92, which forecasts a 2.19% increase in the stock price over the next year. The lowest target is $65 and the highest is $135.
Price Target: $101.92 (+2.19%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 7, 2025.
Analyst Ratings
The average analyst rating for Rhythm Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 → $100 | Strong Buy | Maintains | $80 → $100 | +0.26% | Aug 7, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $100 → $109 | Buy | Maintains | $100 → $109 | +9.28% | Aug 6, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $130 → $135 | Buy | Maintains | $130 → $135 | +35.35% | Aug 6, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $119 → $120 | Strong Buy | Maintains | $119 → $120 | +20.31% | Aug 6, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $92 → $105 | Strong Buy | Maintains | $92 → $105 | +5.27% | Jul 18, 2025 |
Financial Forecast
Revenue This Year
188.28M
from 130.13M
Increased by 44.69%
Revenue Next Year
307.89M
from 188.28M
Increased by 63.53%
EPS This Year
-3.02
from -4.34
EPS Next Year
-2.04
from -3.02
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 208.1M | 385.5M | |||
| Avg | 188.3M | 307.9M | |||
| Low | 170.8M | 236.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 59.9% | 104.7% | |||
| Avg | 44.7% | 63.5% | |||
| Low | 31.3% | 25.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.53 | -0.28 | |||
| Avg | -3.02 | -2.04 | |||
| Low | -3.34 | -3.59 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.